ArticleFrontiers in pharmacology2026

A phase I clinical trial evaluating the effect of food on the pharmacokinetics of TSL-1502, a glucuronide prodrug of a novel oral poly (ADP-ribose) polymerase inhibitor, in healthy Chinese subjects.

Jing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.